These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30442225)

  • 21. Impact of donor age on cardiac transplantation outcomes and on cardiac function.
    Chamogeorgakis T; Joseph S; Hall S; Gonzalez-Stawinski GV; Saracino G; Rafael A; MacHannaford J; Toumpoulis I; Mendez J; Lima B
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):580-3. PubMed ID: 27252239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation.
    Byrne JG; Leacche M; Paul S; Mihaljevic T; Rawn JD; Shernan SK; Mudge GH; Stevenson LW
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):327-32. PubMed ID: 15019656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition.
    Dronavalli VB; Rogers CA; Banner NR
    Transplantation; 2015 Sep; 99(9):1919-25. PubMed ID: 25742423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report from a consensus conference on primary graft dysfunction after cardiac transplantation.
    Kobashigawa J; Zuckermann A; Macdonald P; Leprince P; Esmailian F; Luu M; Mancini D; Patel J; Razi R; Reichenspurner H; Russell S; Segovia J; Smedira N; Stehlik J; Wagner F;
    J Heart Lung Transplant; 2014 Apr; 33(4):327-40. PubMed ID: 24661451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Clinical Characteristics, Complications, and Outcomes in Recipients Having Heart Transplants <65 Years of Age Versus ≥65 Years of Age.
    Jamil A; Qin H; Felius J; Saracino G; Rafael AE; MacHannaford JC; Gonzalez-Stawinski GV; Lima B
    Am J Cardiol; 2017 Dec; 120(12):2207-2212. PubMed ID: 29056228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary graft dysfunction after heart transplantation: Outcomes and resource utilization.
    Quader M; Hawkins RB; Mehaffey JH; Mazimba S; Ailawadi G; Yarboro L; Rich J; Speir A; Fonner C; Wolfe L; Kasirajan V;
    J Card Surg; 2019 Dec; 34(12):1519-1525. PubMed ID: 31609510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation.
    Méndez AB; Ordonez-Llanos J; Mirabet S; Galan J; Maestre ML; Brossa V; Rivilla MT; López L; Koller T; Sionis A; Roig E
    Transplant Proc; 2016 Nov; 48(9):3021-3023. PubMed ID: 27932136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation: A Single-center Experience.
    Quintana-Quezada RA; Rajapreyar I; Postalian-Yrausquin A; Yeh YC; Choi S; Akkanti B; Sieg A; Weeks P; Patel M; Patel J; Nathan S; Kar B; Loyalka P; Gregoric I
    Transplant Proc; 2016; 48(6):2168-71. PubMed ID: 27569965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
    Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
    Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of controlled hypothermic preservation on outcomes following heart transplantation.
    D'Alessandro D; Schroder J; Meyer DM; Vidic A; Shudo Y; Silvestry S; Leacche M; Sciortino CM; Rodrigo ME; Pham SM; Copeland H; Jacobs JP; Kawabori M; Takeda K; Zuckermann A
    J Heart Lung Transplant; 2024 Jul; 43(7):1153-1161. PubMed ID: 38503386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.
    Seguchi O; Fujita T; Murata Y; Sunami H; Sato T; Watanabe T; Nakajima S; Kuroda K; Hisamatsu E; Sato T; Yanase M; Hata H; Wada K; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Heart Vessels; 2016 Apr; 31(4):555-62. PubMed ID: 25682298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of patients with primary graft dysfunction after cardiac transplantation.
    Squiers JJ; DiMaio JM; Van Zyl J; Lima B; Gonzalez-Stawisnksi G; Rafael AE; Meyer DM; Hall SA
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1178-1183. PubMed ID: 34100537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.
    Wright M; Takeda K; Mauro C; Jennings D; Kurlansky P; Han J; Truby L; Stein S; Topkara V; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M; Takayama H
    J Heart Lung Transplant; 2017 Nov; 36(11):1226-1233. PubMed ID: 28583372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
    Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.
    Avtaar Singh SS; DAS DE S; Rushton S; Berry C; Al-Attar N
    J Card Fail; 2019 Dec; 25(12):971-977. PubMed ID: 31330297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of post-lung transplant acute kidney injury with mortality is independent of primary graft dysfunction: A cohort study.
    Shashaty MGS; Forker CM; Miano TA; Wu Q; Yang W; Oyster ML; Porteous MK; Cantu EE; Diamond JM; Christie JD
    Clin Transplant; 2019 Oct; 33(10):e13678. PubMed ID: 31355953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.